据悉，包括半岛医疗、华熙生物、锦波生物等40余家供应链企业参与庆典，凸显鹏爱在医美产业链中的 资源整合能力。庆典期间，深圳鹏爱医院携手爱美客（300896）旗下产品臻爱塑菲，共同发布了"上行 美学"项目。据介绍，该项目不局限于追求外在美，更希望以此来传递一种积极向上的精神，用上扬力 取代焦虑，以生命力引领时代，甚至是成为一种文化。 庆典以传统的醒狮表演开场，鹏爱医美控股集团董事长张晨与深圳鹏爱医院总经理潘尤胜共同为祥狮点 睛，象征新篇章的开启。潘尤胜在致辞中回顾了医院从初创到区域性标杆的成长历程。他表示，未来鹏 爱将继续倡导"三正规、安心美"，持续践行"安全塑美"的理念，不断精进医疗技术，努力深耕服务细 节，做好医美服务的生命周期管理，以更先进的审美理念、更好的效果交付，更细致周到的服务，给广 大客户提供卓越的变美体验。 艾尔建美学南二大区销售总监王永俊作为合作厂商代表发言，他回顾了与鹏爱长达十余年的合作，从保 妥适产品扩展到乔雅登玻尿酸等多品类布局。王永俊表示，双方共同经历了医美市场规范化进程，未来 将聚焦行业健康发展，为客户提供更加优质的产品和服务。 中证报中证网讯(王珞)近日，深圳鹏爱医疗美容医院在院内 ...

Core Insights - The medical beauty industry is projected to show diverse trends by 2025, with light medical beauty becoming mainstream, accounting for 52% of the market, driven by its low trauma, quick recovery, and low risk [1][6][9] - The compound annual growth rate (CAGR) for both light medical beauty and injection categories is expected to reach 20%-30% over the next five years, with popular treatments including water light needles and photon rejuvenation [1][10] - The male medical beauty market is rapidly growing, with 73% of men planning to increase their investment, focusing on anti-aging and minor adjustments [1][21][24] Light Medical Beauty - Light medical beauty is characterized by minimal trauma and short recovery times, making it appealing to first-time consumers [8][13] - The interest demographic is predominantly female (89%), with over 60% of interested individuals aged 18-29 [1][14] - Key concerns for consumers include product compliance, safety, and efficacy, with 72.4% prioritizing compliance [16][17] Male Medical Beauty - The male medical beauty market is emerging as a significant growth area, with a focus on natural and youthful appearances [21][24] - Core pain points for male consumers include nasolabial folds and tear troughs, with anti-aging and minor adjustments being the primary demands [28][29] - Social media plays a crucial role in reshaping male beauty perceptions, with a notable increase in male interest in medical beauty [25][31] Cross-Border Medical Beauty - There is a growing trend for cross-border medical beauty, particularly to South Korea and Hong Kong, driven by high cost-effectiveness and professional services [1][34][35] - The proportion of consumers planning to seek cross-border medical beauty services is expected to rise, with 62% favoring South Korea as a destination [35][36] Youthful Trends - The youth demographic, particularly students after high school, is becoming a significant consumer group for medical beauty, favoring procedures like double eyelid surgery and photon rejuvenation [1][6] - The market for medical beauty products is projected to reach 25.38 billion yuan by 2026, with a CAGR of 30% [1][37] Cross-Industry Integration - Beauty companies are increasingly entering the medical beauty sector, with medical-grade dressings becoming popular entry products [1][6] - Companies like Huaxi Biological and Shanghai Jahwa are launching products focused on collagen and hyaluronic acid, indicating a trend towards combining beauty and medical treatments [1][6]

Core Insights - The luxury beauty brands Helena and La Mer are facing a trust crisis due to issues such as order cancellations and subpar packaging during the 618 shopping festival, leading to a disconnect between sales and reputation [1][2][3] - Despite the negative publicity, these brands still ranked high in sales on platforms like Tmall and Douyin, indicating a complex market dynamic where brand prestige remains but consumer trust is eroding [2][3] Group 1: Sales and Market Performance - Helena's high-end cosmetics division showed the lowest growth rate in L'Oréal's 2024 financial report, with sales declines noted for brands like Helena and Lancôme in China, while YSL and others maintained strong growth [3] - La Mer's parent company, Estée Lauder, reported a 7% and 12% year-over-year revenue decline in Q3 and Q4 of 2024, primarily attributed to decreased sales of La Mer and Estée Lauder products [3] Group 2: Pricing and Service Issues - The traditional pricing control that maintained the high-end image of luxury beauty brands has collapsed, with significant price discrepancies observed across platforms during the 618 festival [5][10] - Consumers reported confusion over pricing, with some products being sold at nearly half the price in duty-free shops compared to official retail channels, leading to concerns about product authenticity [8][10] Group 3: Consumer Behavior and Market Trends - The rise of domestic brands offering high cost-performance ratios is squeezing the luxury beauty market, as younger consumers increasingly question the value of high-priced foreign brands [14][15] - The shift towards medical beauty treatments is also diverting consumer spending away from traditional luxury skincare products, as consumers seek more effective solutions for skin issues [15]

Investment Rating - The report maintains a "Positive" outlook on international cosmetics and medical beauty companies for Q1 2025 [2]. Core Insights - The global beauty market is projected to grow at a rate of 4.5% in 2024, a decline from the 8% growth seen in 2023, with significant regional disparities [3][12]. - The North Asia market, particularly China, has shown signs of improvement, but overall performance remains subdued, with North America exhibiting signs of fatigue [3][12]. - International beauty groups are still grappling with performance declines or slower growth, which may become the new normal due to various factors including the pandemic and macroeconomic conditions [3][15]. - Companies are adopting localization strategies and investing in local brands to maintain market share amid fierce competition from domestic brands [3][19]. Summary by Sections 1. Global Beauty Market Trends - The beauty market continues a stable trend from 2024, with Europe outperforming other regions at a 7.5% growth, while North Asia has seen a 2% decline [3][12]. - The international beauty groups are facing a challenging environment with performance fluctuations and strategic adjustments [15]. 2. L'Oréal Performance - L'Oréal's Q1 2025 revenue growth slowed to 4.4%, with the Chinese market remaining flat and tourism retail channels under pressure [3][27]. - The company is actively investing in local brands and expanding its product matrix to compete with domestic brands [3][27]. 3. Estée Lauder Performance - Estée Lauder reported a 9.9% decline in revenue for Q1 2025, continuing a trend of three consecutive quarters of revenue decline [3][51]. - The company is undergoing strategic reforms to address issues related to brand and product positioning [47][51]. 4. Shiseido Performance - Shiseido's revenue decreased by 8.5% in Q1 2025, with its main brand struggling while the ELIXIR brand showed growth [3][18]. - The company is focusing on strategic product launches and price adjustments to enhance profitability [3][27]. 5. Investment Recommendations - Recommended companies include Up Beauty and Proya for their strong brand matrices and growth potential, as well as Marubi for leveraging Douyin traffic [4]. - In the medical beauty sector, companies with strong R&D capabilities and broad product pipelines, such as Aimeike, are highlighted as key investment opportunities [4].